期刊文献+

结肠癌肝转移机制的研究 被引量:3

Study on mechanism of liver metastasis of colon cancer
下载PDF
导出
摘要 目的:研究影响结肠癌肝转移的可能机制。方法 :脾脏注射小鼠结肠癌细胞,构建大鼠结肠癌肝转移模型。实验分成正常组、门静脉分支结扎组、门静脉结扎组和CCl4诱导肝硬化动物模型组,检测各组大鼠肿瘤肝转移发生率、门静脉压力(portal pressure,PP)、血浆丙氨酸转氨酶(alanine aminotransferase,ALT)水平、肝细胞生长因子(hepatocyte growth factor,HGF)和表皮生长因子(epidermal growth factor,EGF)水平。结果 :PP的变化与肿瘤肝转移发生率不完全一致,未发现血浆ALT水平和肝脏转移肿瘤发生之间具有相关性。肝脏HGF和EGF水平与肿瘤肝转移发生率密切相关。结论:影响结肠癌肝转移发生率的因素有很多,除PP外,HGF和EGF所构成的肝脏微环境变化也起重要作用。 Objective To study the possible mechanism of liver metastasis of colon cancer. Methods The liver metastasis model of colon cancer in the rat was induced by injection of murine colon carcinoma cells in spleen. There were normal group, portal branch ligation group, portal vein ligation group and the group of liver cirrhosis induced by CCl4 in this study. The incidence of liver metastasis, portal pressure(PP), alanine aminotransferase of plasma(ALT), hepatocyte growth factor(HGF) and epidermal growth factor(EGF) were analyzed. Results Both PP and plasma ALT levels was not related to liver metastasis incidence. The levels of liver HGF and EGF, however, were closely related to the incidence of liver metastasis. Conclusions There are many factors that affect the liver metastases of colon cancer, including HGF and EGF in addition to PP.
出处 《外科理论与实践》 2015年第3期232-235,共4页 Journal of Surgery Concepts & Practice
关键词 结肠癌肝转移 肝细胞生长因子 表皮生长因子 门静脉压力 Liver metastasis of colon cancer Hepatocyte growth factor Epidermal growth factor Portal pressure
  • 相关文献

参考文献4

二级参考文献43

  • 1王皓,杨再兴,高春芳,万漠彬,王晓今,Senait Mengsteab,Axel M.Gressner,Ralf Weiskirchen.TGF-β1基因多态性与肝炎后肝纤维化的相关性研究[J].第二军医大学学报,2004,25(12):1284-1287. 被引量:5
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 3李锐,张晓航,张萍,丁俊,郭燕丽,薛雅芳,陈朝辉.实时超声造影与增强螺旋CT检出恶性肿瘤肝转移灶的临床研究[J].临床超声医学杂志,2006,8(12):708-710. 被引量:13
  • 4Philips N, Keller T, Gonzalez S. TGF beta-like regulation of matrix metalloproteinases by anti-transforming growth factor-beta, and anti-transforming growth factor-beta 1 antibodies in dermal fibroblasts: implications for wound healing. Wound Repair Regen, 2004,12:53-59.
  • 5Arthur MJ. Fibrogenesis-II. metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 2000,279:245-249.
  • 6Hu MG, Hu GF, Kim Y, et al. Role of p12(CDK2-AP1) in transforming growth factor-beta1-mediated growth suppression. Cancer Res, 2004, 15:490-499.
  • 7de Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev, 2004,15:1-11.
  • 8Massague J, Wotton D. Transcriptional control by the TGF β/Smad signaling system. EMBO J, 2000, 19:1745-1754.
  • 9Dooley S, Hamzavi J, Breitkopf K, et al. Smad 7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology, 2003,125:178-191.
  • 10Cutroneo KR, Phan SH. TGF-beta1-induced Smad 3 binding to the Smad 7 gene: knockout of Smad 7 gene transcription by sense phosphorothioate oligos, autoregulation, and effect on TGF-beta1 secretion: bleomycin acts through TGF-beta1. J Cell Biochem, 2003,89:474-483.

共引文献33

同被引文献14

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部